1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Cerebral Ventriculitis: new trials by email Literature Review of Cerebral Ventriculitis trials Research Report on Cerebral Ventriculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex BV100 with 50 mg polymyxin B plus ceftazidime/avibactam, BV100 with 50 mg polymyxin B plus cefiderocol, Best Available Therapy (BAT) - Ventilator Associated Bacterial Pneumonia (VABP), Hospital Acquired Bacterial Pneumonia (HABP) | Phase 2 | Not yet recruiting | BioVersys AG | 120 | 2026-07-01 | 2026-02-24 |
Central Nervous System Infections (1) · Meningitis, Bacterial (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Brain Diseases (1) · Central Nervous System Bacterial Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Viral Diseases (1) · Encephalitis (1) · Infections (1) · Meningitis (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1)
Cefiderocol (1) · Ceftazidime (1) · Polymyxin B (1) · avibactam (1)
BioVersys AG (1)